The Trust Agency acts as your fully outsourced, regulation-aware link building department for the Korean pharmaceutical industry-combining pure white-hat digital PR with advanced, controlled assets to build authority safely and at scale. From 청구 허가 중심의 B2B 제약 사이트 to global pharma brands entering Korea, we engineer custom backlink strategies that respect medical regulations, protect brand integrity, and win competitive rankings across Korean and international SERPs.
Everything you need for enterprise-grade link building
Every campaign is custom-built, allowing us to design link strategies that respect Korean MFDS regulations, pharma advertising constraints, and strict medical content guidelines. This reduces compliance risk while still building strong organic visibility for prescription, OTC, and healthcare brands.
Our high-authority outreach and digital PR services focus on earning links from reputable health portals, medical publications, university hospitals, and professional associations relevant to Korean pharma audiences. These contextually matched placements boost both search authority and perceived clinical credibility.
Global, international, and multilingual link building capabilities enable campaigns in Korean for Naver/Daum as well as English for international journal and partner sites. This supports Korean pharma companies targeting both domestic healthcare professionals and global markets with localized content.
Our pure white hat and ethical link building services are ideal for highly scrutinized pharmaceutical brands that must avoid spammy or manipulative tactics. By relying on editorial, expert-source, and content-driven links, Korean pharma companies can grow SEO visibility without jeopardizing brand or regulatory standing.
HARO and expert link building services help position Korean medical experts and pharma KOLs as quoted sources in high-authority media and health publications. This strengthens brand trust, supports evidence-based positioning for therapies, and generates powerful authority backlinks to corporate or product sites.
Our EDU and institutional link building services can be aligned with Korean universities, research centers, and academic collaborators where appropriate. These high-trust signals are especially valuable for clinical trial pages, R&D pipelines, and disease-awareness content.
The Trust Agency functions as a complete external link building team, freeing Korean pharma marketing and medical affairs teams from vetting sites and managing complex outreach. This lets internal teams stay focused on compliance, brand, and scientific messaging while we handle execution and reporting.
Transparent reporting and diversified link profiles (editorial, PR, forums, Web 2.0, and more) give enterprise pharma stakeholders clear visibility into risk and ROI. Campaigns can be tuned to maintain conservative, compliance-friendly link mixes while still outpacing competitors in organic reach.
Our proven process for delivering results
Start by telling The Trust Agency about your products, target markets (domestic vs. global), compliance constraints, and priority keywords in the Korean pharmaceutical space. This lets the team design a custom, pharma-safe link building roadmap instead of using a generic template.
The Trust Agency maps out a full-spectrum link strategy combining white-hat PR, medical content placements, and controlled assets that respect MFDS, local advertising rules, and internal review processes. You review and approve the approach, ensuring every link type fits your regulatory and brand guidelines.
Together, you prioritize Korean and global medical portals, industry publications, academic-style resources, and trusted Web 2.0 and niche sites relevant to your therapeutic areas. The team then prepares medically appropriate content angles like disease awareness, R&D updates, and thought leadership that can earn natural, high-authority backlinks.
The Trust Agency executes manual outreach, digital PR, guest posting, and specialized link placements to secure dofollow, contextually relevant backlinks from vetted pharma-friendly domains. Throughout, they coordinate with your medical, regulatory, and legal teams when needed to ensure every live placement meets compliance and brand standards.
You receive clear reports on acquired links, referring domains, rankings, and organic traffic growth for your Korean pharma assets. Based on results, the link profile is diversified and scaled-balancing pure white-hat authority links with more advanced tactics where appropriate-to build long-term search visibility without compromising regulatory safety.
See how leading companies leverage our advanced link building services
Enterprise-grade link building that delivers measurable results
Every backlink is placed on medically relevant, Korean-language or Korea-facing sites that pass strict checks for regulatory sensitivity, E‑A‑T (Expertise, Authoritativeness, Trustworthiness), and spam risk-critical in the tightly regulated pharmaceutical space. Manual outreach supported by AI prospecting ensures publications align with MOHW/KFDA expectations and do not create compliance or reputation issues.
Specialists in healthcare, life sciences, and pharma content identify reputable Korean medical portals, journals, hospital blogs, and professional associations suitable for compliant link placements. This domain knowledge helps avoid pseudo-medical or fringe sites that could dilute brand credibility or conflict with local advertising regulations for prescription drugs and OTC products.
Campaigns are tailored to the specific goals of Korean pharmaceutical brands-whether boosting generic drug portfolio visibility, patent-cliff launches, DTC awareness within regulatory limits, or B2B clinical/partner outreach. Strategies integrate local keyword research, medical KOL content, and compliance-conscious messaging to attract organic links from trustworthy sources.
Link profiles are built with a deliberate balance of organic medical mentions, educational content, industry news placements, and safer commercial links to minimize regulatory and algorithmic risk. This diversification reduces dependence on any single tactic and helps Korean pharma sites maintain stable visibility through Google and Naver updates.
All placements include full URL lists, medical relevance notes, traffic and authority metrics, and clear disclosure of any sponsored relationships-vital for internal medical/legal review and compliance archives. Korean pharma marketing and regulatory teams can quickly validate that each link aligns with brand and regulatory guidelines.
For Korean pharmaceutical companies expanding into APAC, US, or EU markets, multilingual campaigns secure links from international medical and life science publications while preserving a strong Korean hub. This supports both cross-border clinical trial recruitment and global brand recognition without sacrificing local SEO strength.
High-authority placements on reputable medical journals, university-affiliated sites, and recognized health information portals reinforce your brand’s scientific credibility and domain authority. This is especially important for ranking evidence-based content such as clinical trial data, white papers, and disease education pages in Korea.
Centralizing all pharma-specific link building needs with one specialist partner reduces the overhead of managing multiple agencies, freelance medical writers, and outreach teams. Korean pharma marketers can achieve medical-grade placements at a lower blended cost than building and maintaining an in‑house SEO outreach unit.
Your team no longer spends months sourcing compliant Korean and global medical sites, negotiating placements, and coordinating with medical/legal reviewers for each opportunity. Streamlined workflows and pre-vetted sites accelerate campaign deployment for launches and seasonal health campaigns.
Link building is tied to clear pharma-oriented KPIs such as visibility for disease keywords, traffic to patient education hubs, HCP portal sign-ups, and lead indicators for new drug launches. Ongoing optimization helps reallocate budget toward link types and publishers that demonstrably improve rankings and qualified organic traffic.
Everything you need to know about our link building services
한국 제약·바이오 산업은 엄격한 규제, 의학·과학 기반 콘텐츠, 다국어 커뮤니케이션이 필수라 일반 산업과 완전히 다릅니다. The Trust Agency는 제약·의약/헬스케어 전문 미디어, 학술·의학 커뮤니티, 글로벌/국내 포털 등 제약 특화 자산을 기반으로 한 전용 링크빌딩 전략을 제공합니다.
국내 제약사, 글로벌 제약사의 한국 법인, CRO, CMOs, 원료의약품(API) 업체, 헬스케어 플랫폼 및 의학 콘텐츠 기업까지 모두 지원합니다. 기업 블로그·브랜드 사이트·제품 페이지·학술 콘텐츠 등 다양한 자산에 맞춰 디지털 PR, 게스트 포스팅, Web 2.0, PBN 등 풀 스펙트럼 링크를 설계합니다.
우선순위는 항상 ‘안전한 권위(Authority) 확보’로, 의학·과학 카테고리의 고품질 도메인, 실트래픽 보유 사이트, 관련성 높은 콘텐츠에만 링크를 배치합니다. 화이트햇 디지털 PR, 게스트 포스트, HARO 등 안전한 소스와, 필요 시 신중히 설계된 PBN·Web 2.0를 조합해 리스크 대비가 된 포트폴리오를 구성합니다.
시작 단계에서 K-제약법, 광고 심의, 내부 컴플라이언스 가이드(제품 명시 여부, 질환명 언급 범위 등)를 상세히 수집해 전략에 반영합니다. 이후 제품/질환/타깃 채널별로 화이트햇 중심, 브랜드 중심, 리드/임상시험 모집 중심 등 목적별 맞춤 링크빌딩 플랜을 설계합니다.
규제 리스크와 브랜드 가치가 크기 때문에 1차 권장 전략은 화이트햇·에디토리얼·디지털 PR 중심입니다. 다만 경쟁이 극심한 키워드나 제네릭 제품군처럼 보다 공격적인 전략이 필요한 경우, 별도의 리스크 브리핑과 승인 절차를 거쳐 PBN·Web 2.0 등 고속 성장용 자산을 병행할 수 있습니다.
링크 수, 도메인 권위(DA/DR), 국내 vs 해외 비율, 화이트햇 vs PBN 비중에 따라 맞춤 견적으로 산정됩니다. 한국 제약사 기준으로는 월 수백만 원대의 기본 패키지부터, 다국가 임상·브랜드 캠페인의 경우 월 수천만 원 규모의 엔터프라이즈 플랜까지 확장 가능합니다.
각 월별로 확보된 링크 리스트(URL, 앵커 텍스트, 타깃 페이지, DA/DR, 예상 트래픽), 게재된 콘텐츠 초안 및 최종본, 진행 중/보류 중 기회 리스트를 제공합니다. 또한 캠페인 시작 시 전략 문서, 중간 점검용 개선 제안서 등도 포함해 내부 보고용 자료로 활용할 수 있습니다.
월별 또는 분기별 리포트에서 신규 링크 수, 도메인 권위 변화, 핵심 키워드 순위 추이, 유기적 트래픽 변화 등을 제공합니다. 필요 시 브랜드명·제품명·질환 키워드 그룹별 성과를 분리해, 마케팅·디지털·메디컬팀이 각각 활용하기 쉬운 형태로 커스터마이징할 수 있습니다.
네, 완전 화이트라벨 형태로 서비스 제공이 가능하며, 리포트·프리젠테이션·캠페인 계획서에서 The Trust Agency의 브랜드는 노출되지 않습니다. 한국 로컬 파트너사 또는 글로벌 본사 인하우스 팀 명의로 커스터마이징된 템플릿과 대시보드를 제공해 내부 보고 체계를 그대로 유지할 수 있습니다.
일반적으로 2~3개월부터 인덱싱 및 초기 신호가 보이고, 경쟁 키워드 기준 4~6개월 이후부터 의미 있는 순위·트래픽 변화를 기대할 수 있습니다. 검색 알고리즘과 경쟁 상황 변수로 특정 순위를 절대 보장하지는 않지만, 사전에 합의한 KPI(순위 구간, 유기 트래픽, 레퍼링 도메인 수 등)를 기준으로 성과를 관리합니다.
Get started with The Trust Agency and unlock enterprise-grade link building that delivers measurable SEO results.
Instant access to 100,000+ backlinks, innovative SEO tools, and expert support.
Already have an account? Sign in